JD Health International Inc.
JD Health International Inc.
- Market cap
- $29.07B
- P/E ratio
- 15.42
Your view on JDHIY
Overview
What the company does, where it operates, and who runs it.
About JD Health International Inc.
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Cao Dong
- Headquarters
- Jingdong Headquarters, Beijing, CN
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Cao Dong
- Headquarters
- Jingdong Headquarters, Beijing, CN
JD Health International Inc., an investment holding company, operates an online healthcare platform in the People's Republic of China.
It offers pharmaceutical and healthcare products, including OTC drugs, prescription drugs, and medical devices and supplies, as well as health supplements and tonics through direct selling and an online retail pharmacy network.
The company also provides online healthcare services, online consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services; health management and intelligent healthcare solutions, as well as technical and advertising services.
In addition, it offers access to medical checkups, medical aesthetics, vaccination appointments, dental care services, and nucleic acid testing tests. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for JD Health International Inc. from FRC's valuation model, read against the market price. JDHIY last traded at $9.08, 15.4× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for JD Health International Inc.. Starting points for JD Health International Inc.: P/E 15.4, EPS $1.94, beta 1.19 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for JD Health International Inc.. JD Health International Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for JD Health International Inc.. Trailing twelve-month EPS for JD Health International Inc. stands at $1.94. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Earnings Estimate
| EPS | Current QtrSep 2024 | Next QtrDec 2024 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | CNY 0.00 | CNY 0.00 | CNY 0.00 | CNY 0.00 |
| Low estimate | CNY 0.00 | CNY 0.00 | CNY 0.00 | CNY 0.00 |
| High estimate | CNY 0.00 | CNY 0.00 | CNY 0.00 | CNY 0.00 |
| No. of analysts | 0 | 0 | 0 | 0 |
| Year-ago EPS | — | — | CNY 1.61 | — |
| Growth | — | — | −100.0% | — |
Revenue Estimate
| Revenue | Current QtrSep 2024 | Next QtrDec 2024 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | CNY 13.30B | CNY 16.42B | CNY 84.91B | CNY 97.09B |
| Low estimate | CNY 13.30B | CNY 16.42B | CNY 84.07B | CNY 92.52B |
| High estimate | CNY 13.30B | CNY 16.42B | CNY 86.96B | CNY 102.96B |
| No. of analysts | 1 | 1 | 16 | 17 |
| Year-ago revenue | — | — | CNY 71.44B | — |
| Growth | — | — | +18.9% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 20, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for JD Health International Inc.. JD Health International Inc. has reported as a listed company since 2022. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | Mkt cap |
|---|---|---|---|---|---|
| ALBBYAlibaba Health Information Technology Limited | Healthcare | Medical - Healthcare Information Services | $12.4B | ||
| HIMSHims & Hers Health, Inc. | Healthcare | Medical - Care Facilities | $3.9B | ||
| MNDRMobile-health Network Solutions Class A Ordinary Shares | Healthcare | Medical - Care Facilities | $23,376 | ||
| PIAHYPing An Healthcare and Technology Company Limited | Healthcare | Medical - Healthcare Information Services | $2.4B | ||
| POMPOMDOCTOR Ltd | Healthcare | Medical - Pharmaceuticals | $13.8M | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| PRPHProPhase Labs, Inc. | Healthcare | NASDAQ | $331,590 | ||
| PXYNPraxsyn Corporation | Healthcare | OTC | $6,347 | ||
| QMDTQuick-Med Technologies, Inc. | Healthcare | OTC | $11,204 | ||
| RADLYRaia Drogasil S.A. | Healthcare | OTC | $8.8B | ||
| RBIIRising BioSciences, Inc. | Healthcare | OTC | $4,991 | ||
| RCDTFRecordati Industria Chimica e Farmaceutica S.p.A. | Healthcare | OTC | $11.6B | ||
| RGEDFGedeon Richter PLC | Healthcare | OTC | $5.7B | ||
| RLLVFRelevium Technologies Inc. | Healthcare | OTC | $2.0M | ||
| RMRKRimrock Gold Corp. | Healthcare | OTC | $234,228 | ||
| ROTHPharmaRoth Labs, Inc. | Healthcare | OTC | $35,118 | ||
| RPGLFRegent Pacific Group Limited | Healthcare | OTC | $36.5M | ||
| RPRXRoyalty Pharma plc | Healthcare | NASDAQ | $30.6B | ||
| Ticker | Fund | Fund assets | % of the fund |
|---|---|---|---|
| NTSEWisdomTree Emerging Markets Efficient Core Fund | $51M in assets | 0.03% | |
Largest holders first, then the funds most concentrated in JDHIY.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for JD Health International Inc.. Coverage tracks JD Health International Inc. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of JD Health International Inc.